Agenus (AGEN)
(Delayed Data from NSDQ)
$13.26 USD
+1.14 (9.41%)
Updated May 1, 2024 04:00 PM ET
After-Market: $13.24 -0.02 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AGEN 13.26 +1.14(9.41%)
Will AGEN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGEN
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
AGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
Other News for AGEN
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
Agenus regains compliance with Nasdaq minimum bid price requirement
Agenus regains compliance with Nasdaq
What to Make of Agenus Stock (NASDAQ:AGEN) Post Reverse Stock Split
Time Is Running Out For Agenus To Raise Cash